Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,177)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05778708 | Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients | recruiting | N/A | 318 | The University of Hong KongOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05698264 | A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC | not yet recruiting | N/A | 50 | Nir PeledOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04720339 |
| Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy. |
| recruiting |
| N/A |
| 250 |
| University Hospital, Strasbourg, FranceOTHER |
| 1 |
| Nov 23, 2022 |
| clinicaltrials |
| NCT02354274 | Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine® | recruiting | N/A | 330 | Olfred HansenOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT05033691 | A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases | recruiting | N/A | 162 | Hadassah Medical OrganizationOTHER | 1 | Sep 5, 2021 | clinicaltrials |
Data updated 23 days agoSource updated May 10, 2023source: clinicaltrials